Elutia Inc. (ELUT)

NASDAQ: ELUT · Real-Time Price · USD

1.070

-0.050 (-4.46%)

Mar 26, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cardiovascular	3.16M	2.91M	5.04M	7.28M	-
Cardiovascular Growth	8.27%	-42.18%	-30.79%	-	-
Women's Health	9.14M	11.55M	10.30M	7.47M	-
Women's Health Growth	-20.90%	12.12%	37.86%	-	-
Device Protection	-	-	9.40M	9.09M	-
Device Protection Growth	-	-	3.39%	-	-
Regenerative Medicines	-	-	-	-	47.39M
Regenerative Medicines Growth	-	-	-	-	11.03%
Total	12.29M	14.47M	24.75M	23.85M	47.39M
Total Growth	-15.03%	-41.54%	3.76%	-49.68%	11.03%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	12.29M	14.47M	24.75M	23.85M	47.39M
United States Growth	-15.03%	-41.54%	3.76%	-49.68%	11.03%
Total	12.29M	14.47M	24.75M	23.85M	47.39M
Total Growth	-15.03%	-41.54%	3.76%	-49.68%	11.03%

Source: S&P Global Market Intelligence.